New Page Name
Arthrosamid® is a 2.5% injectable polyacrylamide hydrogel (iPAAG), made of a non-biodegradable, water-rich gel that integrates with the knee’s synovial lining to reduce stiffness and pain. It’s supplied as six pre-filled 1 mL syringes (total 6 mL). This is an innovative treatment transforming knee osteoarthritis therapy. Unlike traditional treatments that need frequent repetition, this single injection provides long-lasting relief by creating a permanent scaffold within your knee joint.
I have been performing ultrasound-guided knee injections for over 10 years, including thousands of procedures through my NHS consultant role. What sets Arthrosamid apart as a treatment option is its unique mechanism, rather than simply lubricating the joint like a hyaluronic acid injection, it becomes part of the joint lining, creating a cushioning scaffold that supports your knee every time you move. Arthrosamid hydrogel can offer long lasting pain relief maintained for 5 years after the injection in recent research (Bliddal, H., et al. 2025).

How Does Arthrosamid Work?
Hydrogels like Arthrosamid® have been used safely in urogynecology for stress urinary incontinence for many years. It’s also been successfully used in horses’ knees over the last decade, being adapted for human knee injectable treatment.
When I inject Arthrosamid into your knee joint, it doesn’t provide immediate relief like a steroid injection. Instead, over the following months, it integrates with your joint capsule, the ‘bag’ surrounding your knee joint. This creates a permanent cushion-like scaffold that stabilizes the joint and limits compression when you walk or move.
Think of it as putting scaffolding around a building to provide structural support. The gel merges with your joint capsule, preventing it from folding and compressing excessively during movement, which reduces pain and improves function.
Relief often starts in weeks, builds over 1–3 months, and has been maintained in studies through at least 3 years, while 5-year effectiveness and 10-year safety have been presented in research more recently (Bliddal, H., et al. 2025).
Arthrosamid Knee Injection Post-Treatment Timeline: When You’ll Feel the Difference
Understanding the Arthrosamid timeline helps set realistic expectations:
First 48 Hours: Complete rest as advised including driving. You may experience some tenderness or mild swelling around the injection site for 24h, it affects around 12% of patients – this is completely normal as your body begins responding to the treatment.
Week 1 to 2: Rest period with possible mild swelling or stiffness. Most patients manage normal daily activities but should avoid strenuous exercise, heavy lifting, or prolonged standing.
Weeks 3-4: Many patients notice decreased pain levels within just four weeks, allowing for improved mobility and quality of life. This is when you can gradually return to normal activities with greater confidence.
Months 1-3: The hydrogel integrates with your joint tissues. Most patients begin experiencing significant pain relief and improved function during this period, with a gradual return to everyday activities with less discomfort.
3-12 months: Clinical studies show this is when maximum benefit is typically achieved, with improvements continuing throughout the first year.
Years 2-4+: Sustained benefit period. Research demonstrates maintained pain relief and functional improvement for at least four years.
The Treatment Process: What Happens When You Come to See Me
First, we’ll have a telephone consultation where I review your symptoms, previous treatments, and imaging. This usually takes 15-30 minutes, though occasionally longer for complex cases. For straightforward candidates, I can sometimes arrange direct booking with pre-completed forms.
You’ll need recent imaging (X-ray or MRI) before the procedure. This isn’t just to confirm osteoarthritis – I can assess that clinically and with ultrasound on the day. The imaging helps exclude other conditions that might mimic arthritis symptoms and ensure we’re not missing anything significant.
On procedure day, I perform an ultrasound examination to check for acute inflammation, such as severe synovitis (a contraindication for Arthrosamid) or a large build-up of synovial fluid (which can be removed first) and plan the injection approach. The injection itself involves six syringes of Arthrosamid delivered through a single needle entry point, all under ultrasound guidance.



